98 related articles for article (PubMed ID: 14996765)
1. Olanzapine vs haloperidol for treatment of schizophrenia.
Volavka J; Citrome L
JAMA; 2004 Mar; 291(9):1064; author reply 1065-6. PubMed ID: 14996765
[No Abstract] [Full Text] [Related]
2. Olanzapine vs haloperidol for treatment of schizophrenia.
Glazer WM
JAMA; 2004 Mar; 291(9):1064-5; author reply 1065-6. PubMed ID: 14996766
[No Abstract] [Full Text] [Related]
3. Olanzapine vs haloperidol for treatment of schizophrenia.
de Haan L; van Beveren N
JAMA; 2004 Mar; 291(9):1065; author reply 1065-6. PubMed ID: 14996769
[No Abstract] [Full Text] [Related]
4. Reduction in tardive dyskinesia symptoms during treatment with olanzapine or haloperidol.
Kinon BJ; Kollack-Walker S; Stauffer V; Liu-Seifert H
J Clin Psychopharmacol; 2012 Jun; 32(3):420-2. PubMed ID: 22561475
[No Abstract] [Full Text] [Related]
5. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.
Rosenheck R; Perlick D; Bingham S; Liu-Mares W; Collins J; Warren S; Leslie D; Allan E; Campbell EC; Caroff S; Corwin J; Davis L; Douyon R; Dunn L; Evans D; Frecska E; Grabowski J; Graeber D; Herz L; Kwon K; Lawson W; Mena F; Sheikh J; Smelson D; Smith-Gamble V;
JAMA; 2003 Nov; 290(20):2693-702. PubMed ID: 14645311
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine vs haloperidol for treatment of schizophrenia.
Kunz M
JAMA; 2004 Mar; 291(9):1065; author reply 1065-6. PubMed ID: 14996768
[No Abstract] [Full Text] [Related]
7. Olanzapine vs haloperidol for treatment of schizophrenia.
Amin M; Shukla VS
JAMA; 2004 Mar; 291(9):1065; author reply 1065-6. PubMed ID: 14996767
[No Abstract] [Full Text] [Related]
8. Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: results of the Japan multicenter, double-blind olanzapine trial.
Ishigooka J; Inada T; Miura S
Psychiatry Clin Neurosci; 2001 Aug; 55(4):403-14. PubMed ID: 11442893
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine and haloperidol for residual symptoms.
de Haan L; van Beveren N
Am J Psychiatry; 2005 Jul; 162(7):1392-3; author reply 1393. PubMed ID: 15994737
[No Abstract] [Full Text] [Related]
10. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial.
Beasley CM; Tollefson G; Tran P; Satterlee W; Sanger T; Hamilton S
Neuropsychopharmacology; 1996 Feb; 14(2):111-23. PubMed ID: 8822534
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine monotherapy for late-onset vocal tics in a schizophrenic patient.
Cheng WJ; Liu HC; Huang MC
Psychiatry Clin Neurosci; 2007 Dec; 61(6):700-1. PubMed ID: 18081638
[No Abstract] [Full Text] [Related]
13. Olanzapine-induced tardive dystonia successfully treated by tetrabenazine.
Rauchverger B; Isakov V; Jabarin M
J Neuropsychiatry Clin Neurosci; 2007; 19(4):484-5. PubMed ID: 18070868
[No Abstract] [Full Text] [Related]
14. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
Conley RR; Tamminga CA; Bartko JJ; Richardson C; Peszke M; Lingle J; Hegerty J; Love R; Gounaris C; Zaremba S
Am J Psychiatry; 1998 Jul; 155(7):914-20. PubMed ID: 9659857
[TBL] [Abstract][Full Text] [Related]
15. Treatment of clozapine-associated tardive dyskinesia.
Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
[No Abstract] [Full Text] [Related]
16. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
Saddichha S; Ameen S; Akhtar S
J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
[TBL] [Abstract][Full Text] [Related]
17. A post hoc analysis of transitioning to oral treatment with olanzapine or haloperidol after 24-hour intramuscular treatment in acutely agitated adult patients with schizophrenia.
Battaglia J; Houston JP; Ahl J; Meyers AL; Kaiser CJ
Clin Ther; 2005 Oct; 27(10):1612-8. PubMed ID: 16330297
[TBL] [Abstract][Full Text] [Related]
18. [Economic analyses of olanzapine in the treatment of schizophrenia and bipolar disorder].
Dilla T; Prieto L; Ciudad A; Sacristán JA
Actas Esp Psiquiatr; 2004; 32(5):269-79. PubMed ID: 15529211
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
Volavka J; Nolan KA; Kline L; Czobor P; Citrome L; Sheitman B; Lindenmayer JP; McEvoy J; Lieberman JA
Schizophr Res; 2005 Jul; 76(1):127-9. PubMed ID: 15927808
[No Abstract] [Full Text] [Related]
20. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
Keefe RS; Seidman LJ; Christensen BK; Hamer RM; Sharma T; Sitskoorn MM; Lewine RR; Yurgelun-Todd DA; Gur RC; Tohen M; Tollefson GD; Sanger TM; Lieberman JA
Am J Psychiatry; 2004 Jun; 161(6):985-95. PubMed ID: 15169686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]